Home > Boards > US Listed > Biotechs > MediciNova, Inc. (MNOV)

S3 filed 12/1/2015: http://www.sec.gov/Archives/edgar/data/1226616/000119312515391096/d68859ds3.htm

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Minding Member Profile
 
Followed By 15
Posts 830
Boards Moderated 0
Alias Born 03/03/10
160x600 placeholder
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 6/21/2019 12:13:09 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/13/2019 5:07:04 PM
MediciNova to Present at the JMP Securities Life Sciences Conference GlobeNewswire Inc. - 6/12/2019 7:00:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/11/2019 5:15:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2019 5:05:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2019 5:04:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2019 5:03:53 PM
MediciNova Announces Kick-off Meeting to Officially Launch Phase 3 Trial of MN 166 (ibudilast) in ALS GlobeNewswire Inc. - 6/5/2019 7:00:00 PM
MediciNova to Present at the 20th Annual B. Riley FBR Institutional Investor Conference GlobeNewswire Inc. - 5/15/2019 7:00:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/14/2019 4:42:49 PM
MediciNova Participated in the RECEDE Phase 3 Degenerative Cervical Myelopathy Trial Kick-off Meeting, DCM Symposium and the ... GlobeNewswire Inc. - 5/7/2019 7:00:00 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 5/1/2019 5:29:15 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/26/2019 5:10:33 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/26/2019 6:22:37 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/25/2019 4:33:49 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 4/25/2019 4:20:32 PM
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Glioblastoma GlobeNewswire Inc. - 4/23/2019 7:00:00 PM
MediciNova Announces Plans to Move Forward with a Phase 3 Trial of MN-166 (ibudilast) in ALS GlobeNewswire Inc. - 4/15/2019 7:00:00 PM
MediciNova Receives Notice of Allowance for New Patent Covering MN-001 for the Treatment of Hypertriglyceridemia, Hypercholes... GlobeNewswire Inc. - 4/3/2019 7:00:00 PM
MediciNova Announces Results of Subgroup Analysis from the SPRINT-MS Phase 2b Trial of MN-166 (ibudilast) in Progressive MS GlobeNewswire Inc. - 4/1/2019 7:00:00 PM
MediciNova Announces Upcoming Presentations Regarding the SPRINT-MS Phase 2b Trial of MN-166 (ibudilast) in Progressive Multi... GlobeNewswire Inc. - 3/24/2019 7:00:00 PM
MediciNova Announces MN-001 Research Collaboration with The Jikei University School of Medicine in Tokyo, Japan GlobeNewswire Inc. - 3/5/2019 6:51:25 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/4/2019 6:12:08 AM
MediciNova Announces the Publication of Results of the Animal Model Study of MN‑166 (ibudilast) in Glioblastoma in Scientif... GlobeNewswire Inc. - 2/28/2019 6:00:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/14/2019 6:44:27 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist